title: β-actin-positive mononuclear cells participate in coronary microvascular medial hyperplasia by migrating through adventitia into media, with special reference to microvessel angina.
abstract: Coronary microvascular hyperplasia is a cause of microvessel angina, although the underlying cellular mechanisms remain unclear. We examined how mononuclear cells expressing β-actin (β-MNCs), which were identified in coronary vessels, induce coronary microvascular hyperplasia.The presence of β-MNCs in coronary hyperplastic arterial (HAM) and venous microvessels (HVM) was examined by endomyocardial biopsy in 25 patients with suspected microvessel angina. β-MNCs were identified in 14 HAMs obtained from 11 patients. Basic fibroblast growth factor and heparin sulfate were injected into the infarcted myocardium to induce HAM and HVM in 28 beagles, and then we examined the role of β-MNCs in the onset of HAM and HVM. The following changes were observed after infarction induction in beagles: (a) migration of β-MNCs from the existing microvessels into the interstitial space at 1-2 weeks; (b) those traversing the adventitia into the media, but not intima, of microvessels; (c) their transformation to smooth muscle cells (SMCs) and/or connective tissues (collagen and elastin fibers); (d) and medial hyperplasia without intimal hyperplasia. Medial hyperplasia was classified into SMC-proliferative and both SMC- and connective tissue-proliferative types. β-MNCs expressed CD(34) but did not express other major vessel-related cell markers.β-MNCs are a vascular progenitor, and migrate out of the adventitia into media, and participate in the etiology of coronary microvascular medial hyperplasia.
authors.affiliation: Japan Foundation for Cardiovascular Research, 2-30-17 Narashino-dai, Funabashi, Chiba, Japan.
authors.forename: Yasumi
authors.initials: Y
authors.lastname: Uchida
authors.forename: Haruko
authors.initials: H
authors.lastname: Egami
authors.forename: Yasuto
authors.initials: Y
authors.lastname: Uchida
authors.forename: Yoshiro
authors.initials: Y
authors.lastname: Maezawa
authors.forename: Yuko
authors.initials: Y
authors.lastname: Maezawa
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Tabata
mesh_terms: D000199:Actins / Q000378:metabolism; D000818:Animals; D002465:Cell Movement; D003238:Connective Tissue / Q000473:pathology; D003331:Coronary Vessels / Q000473:pathology*; D004285:Dogs; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000008:administration & dosage; D006497:Heparan Sulfate / Q000008:administration & dosage; D006801:Humans; D006965:Hyperplasia / Q000209:etiology; D008297:Male; D017566:Microvascular Angina / Q000209:etiology / Q000473:pathology*; D055806:Microvessels / Q000473:pathology*; D008875:Middle Aged; D017540:Tunica Media / Q000473:pathology
chemical_list: D000199:Actins; D016222:Fibroblast Growth Factor 2; D006497:Heparan Sulfate